The use of cellphone based automated pupillometry to quantify opioid withdrawal in patients receiving treatment for opioid use disorder.  Evonko CJ, Vigilante KC, Leli NB, Pond RS Jr, Chaney MW, Ludington JD, Van Leuven EG, Washington WD, MacQ…

Medications to Treat Opioid Use Disorder.  Walter K.  JAMA. Published online February 11, 2026. doi:10.1001/jama.2025.27010 https://jamanetwork.com/journals/jama/fullarticle/2845041

Evaluating the optimal duration of medication treatment for opioid use disorder.  Hayes CJ, Raciborski RA, Acharya M, Noor NB, Nunes EV, Winhusen TJ.  Addiction. 2026 Jan 7. doi: 10.1111/add.70211. Epub ahead of print. PMID: 41501983. h…

Willingness to receive medication for opioid use disorder (MOUD): A longitudinal analysis of social network support.  Knudsen HK, Rockett M, Oser CB.  Drug Alcohol Depend. 2025 Dec 1;277:112966. doi: 10.1016/j.drugalcdep.2025.112966. Epu…

PREMOS - Predictors, Moderators and Outcome of Substitution Treatments – Effekte der langfristigen Substitution Opioidabhängiger: Prädiktoren, Moderatoren und Outcome Schlussbericht an das Bundesministerium für Gesundheit (Förderkennzeichen IIA2-25…

Will blockbuster obesity drugs revolutionize addiction treatment? Scientists are testing whether GLP-1 drugs can help to cut cravings for cigarettes, alcohol and opioids — as well as food. (Nature News, USA, 02.12.2025) https://www.nature.com/arti…